Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies

NCT02897375 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02897375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
October 24, 2016
Completion date
October 15, 2021
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cancer of unknown primary, colorectal cancer, head and neck cancer, ovarian cancer, sarcoma, solid neoplasm, stage iii pancreatic cancer, stage iiia breast cancer, stage iiia non-small cell lung cancer, stage iiib breast cancer, stage iiib non-small cell lung cancer, stage iiic breast cancer, stage iv breast cancer, stage iv non-small cell lung cancer, stage iva pancreatic cancer, stage ivb pancreatic cancer